Showing 59,761 - 59,780 results of 109,021 for search '(( 5 ((a decrease) OR (mean decrease)) ) OR ( a ((nn decrease) OR (point decrease)) ))', query time: 1.14s Refine Results
  1. 59761

    Image 4_PD-1/PD-L1 inhibitors plus bevacizumab plus chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy for advanced non-small cell lung cancer: a phase 3 RCT based meta-an... by Chao Song (379006)

    Published 2025
    “…However, the PIBC group exhibited a higher incidence of grade 3–5 AEs, serious AEs, grade 3–5 treatment-related AEs (TRAEs) and serious TRAEs. …”
  2. 59762

    Table 3_PD-1/PD-L1 inhibitors plus bevacizumab plus chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy for advanced non-small cell lung cancer: a phase 3 RCT based meta-an... by Chao Song (379006)

    Published 2025
    “…However, the PIBC group exhibited a higher incidence of grade 3–5 AEs, serious AEs, grade 3–5 treatment-related AEs (TRAEs) and serious TRAEs. …”
  3. 59763

    Image 2_PD-1/PD-L1 inhibitors plus bevacizumab plus chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy for advanced non-small cell lung cancer: a phase 3 RCT based meta-an... by Chao Song (379006)

    Published 2025
    “…However, the PIBC group exhibited a higher incidence of grade 3–5 AEs, serious AEs, grade 3–5 treatment-related AEs (TRAEs) and serious TRAEs. …”
  4. 59764

    Table 7_PD-1/PD-L1 inhibitors plus bevacizumab plus chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy for advanced non-small cell lung cancer: a phase 3 RCT based meta-an... by Chao Song (379006)

    Published 2025
    “…However, the PIBC group exhibited a higher incidence of grade 3–5 AEs, serious AEs, grade 3–5 treatment-related AEs (TRAEs) and serious TRAEs. …”
  5. 59765

    Table 8_PD-1/PD-L1 inhibitors plus bevacizumab plus chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy for advanced non-small cell lung cancer: a phase 3 RCT based meta-an... by Chao Song (379006)

    Published 2025
    “…However, the PIBC group exhibited a higher incidence of grade 3–5 AEs, serious AEs, grade 3–5 treatment-related AEs (TRAEs) and serious TRAEs. …”
  6. 59766

    Table 2_PD-1/PD-L1 inhibitors plus bevacizumab plus chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy for advanced non-small cell lung cancer: a phase 3 RCT based meta-an... by Chao Song (379006)

    Published 2025
    “…However, the PIBC group exhibited a higher incidence of grade 3–5 AEs, serious AEs, grade 3–5 treatment-related AEs (TRAEs) and serious TRAEs. …”
  7. 59767

    Image 3_PD-1/PD-L1 inhibitors plus bevacizumab plus chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy for advanced non-small cell lung cancer: a phase 3 RCT based meta-an... by Chao Song (379006)

    Published 2025
    “…However, the PIBC group exhibited a higher incidence of grade 3–5 AEs, serious AEs, grade 3–5 treatment-related AEs (TRAEs) and serious TRAEs. …”
  8. 59768

    Table 6_PD-1/PD-L1 inhibitors plus bevacizumab plus chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy for advanced non-small cell lung cancer: a phase 3 RCT based meta-an... by Chao Song (379006)

    Published 2025
    “…However, the PIBC group exhibited a higher incidence of grade 3–5 AEs, serious AEs, grade 3–5 treatment-related AEs (TRAEs) and serious TRAEs. …”
  9. 59769

    Table 4_PD-1/PD-L1 inhibitors plus bevacizumab plus chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy for advanced non-small cell lung cancer: a phase 3 RCT based meta-an... by Chao Song (379006)

    Published 2025
    “…However, the PIBC group exhibited a higher incidence of grade 3–5 AEs, serious AEs, grade 3–5 treatment-related AEs (TRAEs) and serious TRAEs. …”
  10. 59770

    Image 1_PD-1/PD-L1 inhibitors plus bevacizumab plus chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy for advanced non-small cell lung cancer: a phase 3 RCT based meta-an... by Chao Song (379006)

    Published 2025
    “…However, the PIBC group exhibited a higher incidence of grade 3–5 AEs, serious AEs, grade 3–5 treatment-related AEs (TRAEs) and serious TRAEs. …”
  11. 59771

    Table 1_PD-1/PD-L1 inhibitors plus bevacizumab plus chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy for advanced non-small cell lung cancer: a phase 3 RCT based meta-an... by Chao Song (379006)

    Published 2025
    “…However, the PIBC group exhibited a higher incidence of grade 3–5 AEs, serious AEs, grade 3–5 treatment-related AEs (TRAEs) and serious TRAEs. …”
  12. 59772

    Image 6_PD-1/PD-L1 inhibitors plus bevacizumab plus chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy for advanced non-small cell lung cancer: a phase 3 RCT based meta-an... by Chao Song (379006)

    Published 2025
    “…However, the PIBC group exhibited a higher incidence of grade 3–5 AEs, serious AEs, grade 3–5 treatment-related AEs (TRAEs) and serious TRAEs. …”
  13. 59773

    (44) <b>Lyophilized Dendritic Exosomes: A Scalable and Stable Solution for Global Integration of Immunotherapy.</b>Presented at: <i>SITC 2025 Spring Scientific: Cellular Therapy fo... by Ramon Gutierrez-Sandoval (21622127)

    Published 2025
    “…Compared to cryopreserved exosomes, the lyophilized formulation achieved equivalent tumor apoptosis (–56.7% viability; +43.8% apoptosis) and a 77.9% reduction in total logistical costs.</p><p dir="ltr">Functional assessments revealed decreased IL-4 and IL-6 (–28.5% and –26.3%), along with elevated IL-17A and IL-2 (+35.7% and +37.2%), indicating reduced immunosuppression and enhanced T-cell activation. …”
  14. 59774

    Skewness of motion profiles in the episodes <i>mfa</i><sub><i>1-2</i></sub>. by Gerald Kastberger (60716)

    Published 2024
    “…Panels C (<i>mfa</i><sub><i>1</i></sub>) and D (<i>mfa</i><sub><i>2</i></sub>) summarize these matches for the five surveillance zones (for the color codes of <i>sz</i><sub><i>1-5</i></sub>, see the survey panel on the top and at the descriptions in the side bars of A,B) and for the entire nest (black color code).…”
  15. 59775

    Monoarylplatinum(II) Complexes with a 2-Phenylpyridyl Ligand and Coordinated Solvent, [Pt(Ar)(Phpy)(solv)] (Phpy = 2-phenylpyridyl; solv = NCCH<sub>3</sub>, dmso). Preparation from... by Takeyoshi Yagyu (2381218)

    Published 2020
    “…A diarylplatinum complex with a monodentate phenylpyridyl ligand, [Pt(C<sub>6</sub>H<sub>3</sub>Me<sub>2</sub>-3,5)<sub>2</sub>(CF<sub>3</sub>PhpyH)(dmso)] (<b>5</b>), was isolated and characterized using X-ray crystallography. …”
  16. 59776

    Nonuniform broadening of cross-peaks in 2D <sup>15</sup>N-HSQC spectra of <sup>15</sup>N/<sup>13</sup>C-labeled αTM1a<sub>1-14</sub>Zip upon addition of unlabeled Lmod2s1. by Dmitri Tolkatchev (2951769)

    Published 2020
    “…(A) and (B) are the spectra of <sup>15</sup>N/<sup>13</sup>C-labeled αTM1a<sub>1-14</sub>Zip (0.45 mM) in the absence and presence of the excess Lmod2s1 (1.5 molar ratio), respectively. …”
  17. 59777

    Cluster analysis of differentially expressed genes in <i>O</i>. <i>asiaticus</i> feeding on four different plant species (<i>A</i>. <i>frigida</i>, <i>L</i>. <i>chinensis</i>, <i>S... by Xunbing Huang (531098)

    Published 2017
    “…<p>Blue indicates low expression and red indicates high expression. A change from red to blue indicates a decrease in value log10 (FPKM+1) from 1.5 to -1.5. …”
  18. 59778
  19. 59779
  20. 59780